Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00130351 | A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma | PHASE3 | COMPLETED | 155 | — | — | Jul 1, 2005 | Aug 1, 2005 | May 19, 2023 | 12 | United States |
| NCT00443482 | Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer) | PHASE2 | COMPLETED | 50 | — | — | Feb 1, 2007 | May 1, 2007 | Mar 28, 2017 | 4 | Germany |
| Name | Type | Description |
|---|---|---|
| formoterol | DEVICE | - |
Inclusion Criteria: * Patients who are capable of understanding the directions for device usage, evaluating device function and completing the patient diary * Patients who have a current diagnosis of asthma * Patients who have a documented forced expiratory volume at 1 second (FEV1) reversibility o...